Early clinical recovery in STEMI cardiogenic shock: insights from the DanGer shock trial
The DanGer Shock trial showed a survival benefit of mAFP use in STEMI-CS, yet about one-third of SoC patients experienced rapid haemodynamic recovery. These 'Fast Recovery' patients were characterized by higher LVEF, younger age, and lower lactate, however discrimination between patients with and without rapid recovery was modest. Distinguishing patients who will recover rapidly remains challenging and warrants further investigation.
Institutions
- University of Copenhagen (DK)
- Universität Hamburg (DE)
- University of Southern Denmark (DK)
- University Hospital Bonn (DE)
- Odense University Hospital (DK)
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Harefield Hospital (GB)
- Medizinische Hochschule Hannover (DE)
- Düsseldorf University Hospital (DE)
- Deutsches Herzzentrum der Charité (DE)
- Universitätsklinikum Würzburg (DE)
- Jena University Hospital (DE)
- Heinrich Heine University Düsseldorf (DE)
- Technische Universität Dresden (DE)
Publication Details
- Journal
- European Heart Journal Acute Cardiovascular Care
- Published
- 2026-03-24
- DOI
- https://doi.org/10.1093/ehjacc/zuag029
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00